期刊文献+

骨相关蛋白与CRF患者并发动脉粥样硬化和瓣膜钙化的相关性 被引量:4

Association of bone-related protein with the presence of atherosclerosis and valvular calcification in CRF patients
下载PDF
导出
摘要 目的探讨骨相关蛋白与慢性肾衰竭(CRF)患者并发动脉粥样硬化和瓣膜钙化的相关性。方法以75例CRF患者(其中有27例存在颈动脉斑块,23例检测到瓣膜钙化)和10例正常对照作为研究对象。采用ELISA法测定各组血中骨桥蛋白(OPN)、胎球蛋白-A(fetuin-A)和基质Gla蛋白(MGP)水平。比较骨相关蛋白水平与各组临床特征之间的关系。结果与对照组比较,CRF患者血中OPN水平显著升高,fetuin-A水平显著降低。存在颈动脉斑块和心脏瓣膜钙化CRF患者的OPN和fetuin-A水平改变尤为明显。OPN水平与颈动脉内膜厚度呈正相关。结论CRF患者血中OPN和fetuin-A水平与其动脉粥样硬化和心脏瓣膜钙化可能有关。 To elucidate the association of bone-related protein with the presence of atherosclerosis and valvular calcification in chronic renal failure (CRF) patients. Methods Bone-related protein levels including osteopontin ( OPN), fetuin-A and matrix GLA protein (MGP) in 75 CRF patients (27 with carotid plaques and 23 with valvular calcification) and 10 age-matched controls were measured by using ELISA, and their relations to clinic manifestation were studied. Results The levels of OPN in CRF patients were significantly higher and fetuin-A levels significantly lower than those in healthy controls. The concentrations of OPN and fetuin-A in CRF patients with carotid plaques and valvular calcification changed significantly. The OPN values were positively related to the mean intima media thickness levels. Conclusion The levels of OPN and fetuin-A may be associated with the presence of atherosclerosis and valvular calcification in CRF patients.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2007年第8期977-980,共4页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(30370653) 上海市教委基金(04BC35)~~
关键词 骨桥蛋白 胎球蛋白-A 基质GLA蛋白 动脉粥样硬化 瓣膜钙化 慢性肾衰竭 osteopontin fetuin-A matrix Gla protein atherosclerosis valvular calcification chronic renal failure
  • 相关文献

参考文献14

  • 1Davies MR,Hruska KA.Pathophysiological mechanisms of vascular calcification in end-stage renal disease[J].Kidney Int,2001,60(2):472-479.
  • 2Wang AY,Woo J,Wang M,et al.Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients[J].J Am Soc Nephrol,2001,12(9):1927-1936.
  • 3Adeera L,Ognjenka K,Brendan B,et al.Cardiovascular disease in patients with chronic kidney disease:getting to the heart of the matter[J].Am J Kidney Dis,2001,38(6):1398-1407.
  • 4Isoda K,Nishikawa K,Kamezawa Y,et al.Osteopontin plays an important role in the development of medial thickening and neointimal formation[J].Circ Res,2002,91(1):77-82.
  • 5Ohmori R,Momiyama Y,Taniguchi H,et al.Plasma osteopontin levels are associated with the presence and extent of coronary artery disease[J].Atherosclerosis,2003,170(2):333-337.
  • 6Nitta K,Ishizuka T,Horita S,et al.Soluble osteopontin and vascular calcification in hemodialysis patients[J].Nephron,2001,89(4):455-458.
  • 7Wada T,McKee MD,Steitz S,et al.Calcification of vascular smooth muscle cell cultures:inhibition by osteopontin[J].Cir Res,1999,84(2):166-178.
  • 8Speer MY,McKee MD,Guldberg RE,et al.Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice:evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo[J].J Exp Med,2002,196(8):1047-1055.
  • 9Heiss A,DuChesne A,Denecke B,et al.Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A.Formation of colloidal calciprotein particles[J].J Biol Chem,2003,278(15):13333-13341.
  • 10Stenvinkel P,Wang K,Qureshi AR,et al.Low fetuin-A levels are associated with cardiovascular death:Impact of variations in the gene encoding fetuin[J].Kidney Int,2005,67(6):2383-2392.

同被引文献63

  • 1王开 ,钱家麒 ,Peter Stenvinkel ,Bengt Lindholm .终末期肾衰竭患者血清胎球蛋白A水平改变与临床预后的关系[J].中华肾脏病杂志,2005,21(2):72-75. 被引量:21
  • 2梁馨苓,史伟,章斌,刘双信,林秋雄,黄美萍,王文健,叶智明,何朝生.终末期肾病患者心血管事件与血清胎球蛋白A及冠脉钙化的关系[J].中华肾脏病杂志,2006,22(6):336-340. 被引量:25
  • 3王宓,王梅,甘良英,李四君,张萌.血液透析患者血浆胎球蛋白A水平及其与血管钙化的关系[J].中国血液净化,2007,6(5):263-266. 被引量:22
  • 4Qunibi WR. Cardiovascular calcification in nondialyzed patients with chronic kidney disease. Semin Dial, 2007,20: 134-138.
  • 5London GM, Marchais SJ, Guerin AP, et al. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curt Opin Nephrol Hypertens, 2005,14:525-531.
  • 6Kizu A, Shioi A, Jono S, et al. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators. J Cell Biochem, 2004,93:1011- 1019.
  • 7Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res, 2000,87:E10-E17.
  • 8Derici U, El Nahas AM. Vascular calcifications in uremia: old concepts and new insights. Semin Dial, 2006,19:60-68.
  • 9Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol, 2004,15:2857-2867.
  • 10Honda H, Qureshi AR, Heimburger O, et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis, 2006,47:139-148.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部